The Drug Enforcement Administration last week published an interim final rule expanding access to medication-assisted treatment under the SUPPORT for Patients and Communities Act of 2018.

Effective Oct. 30, the rule allows certain practitioners to treat more patients; permanently adds nurse practitioners and physician assistants to the definition of “qualifying other practitioner”; and permits practitioners to complete required opioid training in medical school or residency as well as post-residency.

DEA will accept comments on the rule through Jan. 4.

DEA also will accept comments through Jan. 4 on a proposed rule implementing requirements to report suspicious orders of controlled substances under the Preventing Drug Diversion Act of 2018. The rule would offer multiple options for reporting suspicious orders; establish a centralized database for reporting; define key terms; and require specific record-keeping practices.

Related News Articles

Headline
The AHA and dozens of other organizations yesterday urged House and Senate sponsors of the Conrad State 30 and Physician Access Reauthorization Act to…
Headline
The AHA March 27 voiced opposition to the Physician Led and Rural Access to Quality Care Act (H.R. 2191), a bill that would lift the ban on the establishment…
Headline
The Senate March 25 confirmed Marty Makary as the new commissioner of the Food and Drug Administration and Jay Bhattacharya as the new director of the National…
Headline
The Department of Health and Human Services March 18 announced that it renewed the public health emergency for the nation’s opioid crisis an additional 90 days…
Headline
A new initiative launched March 18 by the Dr. Lorna Breen Heroes' Foundation seeks to improve mental health care access for health care workers. The program,…
Headline
The Senate March 14 approved by a vote of 54-46, a continuing resolution to fund the government through Sept. 30. The House passed, by a vote of 217-213, the…